0

Journal Articles

in Oncology
 141-160 of 841 Articles
Special Feature |  March 01, 2011 FREE
Image of the Month—Quiz Case
Roel E. Genders, MD; Bert A. Bonsing, MD; Aart van der Molen, MD; et al.
Arch Surg. 2011;146(3):361. doi:10.1001/archsurg.2011.24-a.
Special Feature |  March 01, 2011 FREE
Image of the Month—Diagnosis
Arch Surg. 2011;146(3):362. doi:10.1001/archsurg.2011.24-b.
Special Feature |  March 01, 2011 FREE
Image of the Month—Diagnosis
Arch Surg. 2011;146(3):366-367. doi:10.1001/archsurg.2011.15-b.
Invited Critique |  February 01, 2011
Injection Site Mass Following Sentinel Node Biopsy for Breast Cancer:  Comment on “Occurrence of Prolonged Injection Site Mass With Methylene Blue but Not Isosulfan Blue After Sentinel Node Procedure”
Kirby I. Bland, MD
Arch Surg. 2011;146(2):142. doi:10.1001/archsurg.2010.322.
Special Feature |  February 01, 2011 FREE
Image of the Month—Diagnosis
Arch Surg. 2011;146(2):238. doi:10.1001/archsurg.2010.339-b.
Correspondence |  February 01, 2011
Routine or Selective Endoscopic Tattooing in Colon Resection for Cancer
Tetsuji Fujita, MD
Arch Surg. 2011;146(2):239. doi:10.1001/archsurg.2010.320.
Correspondence |  February 01, 2011
Routine or Selective Endoscopic Tattooing in Colon Resection for Cancer—Reply
Richard C. Thirlby, MD
Arch Surg. 2011;146(2):239-240. doi:10.1001/archsurg.2010.321.
Original Article |  February 01, 2011 FREE
Occurrence of Prolonged Injection Site Mass With Methylene Blue but Not Isosulfan Blue After the Sentinel Node Procedure
Gina R. Shirah, MD; Marcia E. Bouton, PA-C; Ian K. Komenaka, MD
Arch Surg. 2011;146(2):137-141. doi:10.1001/archsurg.2010.330.
Original Article |  February 01, 2011 FREE
Evaluation of the Role of Magnetic Resonance Spectroscopy in the Diagnosis of Follicular Malignancies of Thyroid
Nikhil Gupta, MS, MRCS(Edin); Binita Goswami, MD, DNB; Veena Chowdhury, MD; et al.
Arch Surg. 2011;146(2):179-182. doi:10.1001/archsurg.2010.345.
Invited Critique |  January 01, 2011
AFP in OLT for HCC?: Another Shadow on the Cave Wall:  Comment on “Evaluation of Absolute Serum α-Fetoprotein Levels in Liver Transplant for Hepatocellular Cancer”
Andrew M. Cameron, MD, PhD
Arch Surg. 2011;146(1):33-34. doi:10.1001/archsurg.2010.280.
Special Feature |  January 01, 2011 FREE
Image of the Month—Quiz Case
Tze-Woei Tan, MBBS; Rogers C. Griffith, MD; Michael P. Vezeridis, MD
Arch Surg. 2011;146(1):115. doi:10.1001/archsurg.2010.296-a.
Special Feature |  January 01, 2011 FREE
Image of the Month—Diagnosis
Arch Surg. 2011;146(1):116. doi:10.1001/archsurg.2010.296-b.
Special Feature |  January 01, 2011 FREE
Image of the Month—Diagnosis
Arch Surg. 2011;146(1):114. doi:10.1001/archsurg.2010.298-b.
Original Article |  January 01, 2011 FREE
Evaluation of Absolute Serum α-Fetoprotein Levels in Liver Transplant for Hepatocellular Cancer
Brian Mailey, MD; Avo Artinyan, MD, MS; Joshua Khalili, BS; et al.
Arch Surg. 2011;146(1):26-33. doi:10.1001/archsurg.2010.295.
Invited Critique |  December 01, 2010
Undertreatment of Patients With Early-Stage Hepatocellular Carcinoma:  Comment on “Racial/Ethnic Disparities in Access to Care and Survival for Patients With Early-Stage Hepatocellular Carcinoma”
Richard D. Schulick, MD
Arch Surg. 2010;145(12):1163-1164. doi:10.1001/archsurg.2010.254.
Special Feature |  December 01, 2010 FREE
Image of the Month—Diagnosis
Arch Surg. 2010;145(12):1210. doi:10.1001/archsurg.2010.274-b.
Special Feature |  December 01, 2010 FREE
Image of the Month—Diagnosis
Arch Surg. 2010;145(12):1212. doi:10.1001/archsurg.2010.268-b.
Original Article |  December 01, 2010 FREE
Intensive Risk-Adjusted Follow-up With the CEA, TPA, CA19.9, and CA72.4 Tumor Marker Panel and Abdominal Ultrasonography to Diagnose Operable Colorectal Cancer Recurrences:  Effect on Survival
Andrea Nicolini, MD; Paola Ferrari, MD; Michael J. Duffy, MD; et al.
Arch Surg. 2010;145(12):1177-1183. doi:10.1001/archsurg.2010.251.
Original Article |  December 01, 2010 FREE
Racial/Ethnic Disparities in Access to Care and Survival for Patients With Early-Stage Hepatocellular Carcinoma
Amit K. Mathur, MD, MS; Nicholas H. Osborne, MD; Raymond J. Lynch, MD, MS; et al.
Arch Surg. 2010;145(12):1158-1163. doi:10.1001/archsurg.2010.272.
Invited Critique |  November 15, 2010
Does Surgeon Volume Matter for Gastric Cancer Surgery?:  Comment on “Surgeon Subspecialty as a Factor in Improving Long-term Outcomes for Gastric Cancer”
Vivian E. Strong, MD
Arch Surg. 2010;145(11):1096-1097. doi:10.1001/archsurg.2010.224.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Ophthalmology
Clinical Sciences  |  May 16, 2013
Association of Ocular and Oculodermal Melanocytosis With the Rate of Uveal Melanoma Metastasis:  Analysis of 7872 Consecutive Eyes
Carol L. Shields, MD; Swathi Kaliki, MD; Michael Livesey, BS; et al.
JAMA Otolaryngology–Head & Neck Surgery
Original Article  |  May 16, 2013
An Oral Cavity Carcinoma Nomogram to Predict Benefit of Adjuvant Radiotherapy
Samuel J. Wang, MD, PhD; Snehal G. Patel, MD; Jatin P. Shah, MD; et al.
JAMA
Viewpoint  |  April 22, 2013
Cost Consequences of the 340B Drug Discount Program
Rena M. Conti, PhD; Peter B. Bach, MD, MAPP
JAMA Internal Medicine
Original Investigation  |  March 18, 2013
Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone Therapy
Karla Kerlikowske, MD; Weiwei Zhu, MS; Rebecca A. Hubbard, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems